Dr. Gari is serving as Chief Business Officer for Vona Oncology. He has held several executive leadership positions in Strategic Planning, Business Development and Commercial Operations at Roche Pharmaceuticals, Roche Diagnostics and as an Investor within Danaher Corporation’s early-stage venture fund. Dr. Gari is serving on several Biotech and Diagnostic start-up Boards. Prior to joining Roche and Danaher, Dr. Gari was Managing Partner at Avicenna LLC, a life sciences and private equity strategy consulting firm based in Denver, CO. He is a Cancer Biologist by training, with a PhD from the University of Colorado and a Master’s in BioScience Enterprise from Cambridge University.